STM2457

CAS No. 2499663-01-1

STM2457( —— )

Catalog No. M24139 CAS No. 2499663-01-1

STM2457 is a first-in-class, highly potent, selective and orally active inhibitor of METTL3 . It can be used for the research of acute myeloid leukaemia (AML).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 225 In Stock
5MG 205 In Stock
10MG 332 In Stock
25MG 550 In Stock
50MG 770 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    STM2457
  • Note
    Research use only, not for human use.
  • Brief Description
    STM2457 is a first-in-class, highly potent, selective and orally active inhibitor of METTL3 . It can be used for the research of acute myeloid leukaemia (AML).
  • Description
    STM2457 is a first-in-class, highly potent, selective and orally active inhibitor of METTL3 . It can be used for the research of acute myeloid leukaemia (AML).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    METTL3
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2499663-01-1
  • Formula Weight
    444.53
  • Molecular Formula
    C25H28N6O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:125 mg/mL (281.20 mM; Need ultrasonic)
  • SMILES
    O=C(C(N=C1N2C=CC=C1)=CC2=O)NCC3=CN4C=C(CNCC5CCCCC5)C=CC4=N3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Wesley Peter Blackaby, et al. Mettl3 inhibitory compounds. WO2020201773A1.
molnova catalog
related products
  • Pomalidomide-C7-NH2 ...

    Pomalidomide-C7-NH2 hydrochloride is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based CRBN ligand and linker used in PROTAC technology.

  • MSC2504877

    MSC2504877 is an inhibitor of tankyrase and enhances the effects of clinical CDK4/6 inhibitors. MSC2504877 suppresses the upregulation of Cyclin D2 and Cyclin E2 caused by palbociclib and enhances the suppression of phospho-Rb.

  • Sibirioside A

    Sibirioside A is a phenylpropanoid glycoside isolated fromScrophulariae Radix.Sibirioside A has the potential for the treatment of diabetes.